Skip to main content

Table 2 GRADE assessment of the outcomes

From: Zinc supplementation in patients with cirrhosis and hepatic encephalopathy: a systematic review and meta-analysis

Certainty assessment

â„– of patients

Effect

Certainty

No. of studies

Study design

Risk of bias

Inconsistency

Indirectness

Imprecision

Other considerations

Zn

Placebo

Absolute (95% CI)

Number connection test

 3

randomized trials

seriousa

not serious

not serious

not serious

publication bias strongly suspected strong associationb

116

111

SMD 0.97 lower (1.75 lower to 0.19 lower)

MODERATE

Digital symbol test

 2

randomized trials

seriousa

not serious

not serious

seriousc

publication bias strongly suspected strong associationb

70

67

SMD 0.44 higher (0.12 lower to 1 higher)

VERY LOW

Serum ammonia lev

 2

randomized trials

seriousa

not serious

not serious

seriousc

publication bias strongly suspected strong associationb

70

67

MD 10.86 lower (25.73 lower to 4.01 higher)

VERY LOW

  1. CI Confidence interval, SMD Standardized mean difference, MD Mean difference
  2. Explanations
  3. aWe downgraded by one level for serious risk of bias: one study was unblinded
  4. bPublication bias was not assessed due to the limited numbers of included trials
  5. cWe downgraded by one level for serious imprecision: the wide confidence interval contains significant benefits and harm